Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leishmania is a genus of protozoan parasites responsible for leishmaniasis, transmitted by sandflies. It exists in two forms: promastigotes in sandflies and amastigotes within mammalian macrophages. Different species cause varying clinical manifestations, including cutaneous, mucocutaneous, and visceral leishmaniasis. Unique molecular features offer potential drug targets. The disease affects millions globally, predominantly in tropical and subtropical regions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leishmania Parasite.